These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 15016089

  • 1. Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex.
    Mela F, Marti M, Ulazzi L, Vaccari E, Zucchini S, Trapella C, Salvadori S, Beani L, Bianchi C, Morari M.
    Eur J Neurosci; 2004 Mar; 19(5):1317-24. PubMed ID: 15016089
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex.
    Marti M, Stocchi S, Paganini F, Mela F, De Risi C, Calo' G, Guerrini R, Barnes TA, Lambert DG, Beani L, Bianchi C, Morari M.
    Br J Pharmacol; 2003 Jan; 138(1):91-8. PubMed ID: 12522077
    [Abstract] [Full Text] [Related]

  • 3. Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.
    Fantin M, Fischetti C, Trapella C, Morari M.
    Br J Pharmacol; 2007 Oct; 152(4):549-55. PubMed ID: 17618307
    [Abstract] [Full Text] [Related]

  • 4. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R, Caló G, Lambert DG, Carrá G, Arduin M, Barnes TA, McDonald J, Rizzi D, Trapella C, Marzola E, Rowbotham DJ, Regoli D, Salvadori S.
    J Med Chem; 2005 Mar 10; 48(5):1421-7. PubMed ID: 15743186
    [Abstract] [Full Text] [Related]

  • 5. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM, Statnick MA, Rorick-Kehn LM, Pintar JE, Ansonoff M, Chen Y, Tucker RC, Ciccocioppo R.
    Pharmacol Ther; 2014 Mar 10; 141(3):283-99. PubMed ID: 24189487
    [Abstract] [Full Text] [Related]

  • 6. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar 10; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 7. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.
    Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C, Prinssen EP.
    Curr Drug Targets; 2007 Jan 10; 8(1):117-35. PubMed ID: 17266536
    [Abstract] [Full Text] [Related]

  • 8. UFP-101, a high affinity antagonist for the nociceptin/orphanin FQ receptor: radioligand and GTPgamma(35)S binding studies.
    McDonald J, Calo G, Guerrini R, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb 10; 367(2):183-7. PubMed ID: 12595960
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
    Rizzi A, Spagnolo B, Wainford RD, Fischetti C, Guerrini R, Marzola G, Baldisserotto A, Salvadori S, Regoli D, Kapusta DR, Calo G.
    Peptides; 2007 Jun 10; 28(6):1240-51. PubMed ID: 17532097
    [Abstract] [Full Text] [Related]

  • 10. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
    Calo G, Rizzi A, Rizzi D, Bigoni R, Guerrini R, Marzola G, Marti M, McDonald J, Morari M, Lambert DG, Salvadori S, Regoli D.
    Br J Pharmacol; 2002 May 10; 136(2):303-11. PubMed ID: 12010780
    [Abstract] [Full Text] [Related]

  • 11. Quantitative study of [(pF)Phe4,Arg14,Lys15]nociceptin/orphanin FQ-NH2 (UFP-102) at NOP receptors in rat periaqueductal gray slices.
    Kuo CJ, Liao YY, Guerrini R, Calo' G, Chiou LC.
    Eur J Pharmacol; 2008 Jan 28; 579(1-3):110-5. PubMed ID: 17976580
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M, Barnes TA, Carra G, McDonald J, Calo G, Guerrini R, Rowbotham DJ, Smith G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 28; 368(6):528-37. PubMed ID: 14598020
    [Abstract] [Full Text] [Related]

  • 13. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study.
    Linari G, Agostini S, Broccardo M, Petrella C, Improta G.
    Pharmacol Res; 2006 Nov 28; 54(5):356-60. PubMed ID: 16979347
    [Abstract] [Full Text] [Related]

  • 14. Binding of the novel radioligand [(3)H]UFP-101 to recombinant human and native rat nociceptin/orphanin FQ receptors.
    Ibba M, Kitayama M, McDonald J, Calo G, Guerrini R, Farkas J, Toth G, Lambert DG.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Dec 28; 378(6):553-61. PubMed ID: 18807245
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity.
    Kapusta DR, Thorkildsen C, Kenigs VA, Meier E, Vinge MM, Quist C, Petersen JS.
    J Pharmacol Exp Ther; 2005 Aug 28; 314(2):652-60. PubMed ID: 15855355
    [Abstract] [Full Text] [Related]

  • 16. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
    Leggett JD, Harbuz MS, Jessop DS, Fulford AJ.
    Neuroscience; 2006 Sep 15; 141(4):2051-7. PubMed ID: 16784820
    [Abstract] [Full Text] [Related]

  • 17. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC, Fan SH, Guerrini R, Caló G.
    Neuropharmacology; 2002 Feb 15; 42(2):246-52. PubMed ID: 11804621
    [Abstract] [Full Text] [Related]

  • 18. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C, Sánchez-Islas E, Pellicer F, Rodríguez-Manzo G, Cruz SL, León-Olea M.
    Eur J Pharmacol; 2008 Feb 26; 581(1-2):77-85. PubMed ID: 18096155
    [Abstract] [Full Text] [Related]

  • 19. Functional coupling of the nociceptin/orphanin FQ receptor in dog brain membranes.
    Johnson EE, McDonald J, Nicol B, Guerrini R, Lambert DG.
    Brain Res; 2004 Apr 02; 1003(1-2):18-25. PubMed ID: 15019559
    [Abstract] [Full Text] [Related]

  • 20. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J, Barnes TA, Calo G, Guerrini R, Rowbotham DJ, Lambert DG.
    Eur J Pharmacol; 2002 May 17; 443(1-3):7-12. PubMed ID: 12044785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.